MRPL52 and breast cancer: As indicated, MRPL52 upregulation apparently increased both cROS and mROS levels in hypoxic BC cells, but not in BC cells exposed to 20% O2 (Figure 9D-E); And Si-MRPL52 dramatically abolished the elevated ROS generation in BC cells caused by hypoxic exposure (Figure S4B-C).